Oncology Clinical Data Abstractor III jobs in United States
cer-icon
Apply on Employer Site
company-logo

N-Power Medicine, Inc. · 11 hours ago

Oncology Clinical Data Abstractor III

N-Power Medicine is a company focused on transforming clinical trials and drug development. They are seeking a Clinical Data Abstractor III to curate high-quality oncology datasets and ensure compliance with policies and standards while collaborating with various teams to improve processes and data collection experiences.

BiotechnologyPharmaceuticalClinical Trials
badNo H1Bnote
Hiring Manager
Leslie Hess
linkedin

Responsibilities

Retrieve, abstract and curate high quality oncology data sets from various EHR platforms into a proprietary NPM or 3rd party electronic data capture (EDC) system
Ensure compliance and confidentiality with NPM and Network Site policies, standard operating procedures (SOPs), and Good Clinical Practice (GCP)
Curate a comprehensive data set including, but not limited to, patient history, diagnosis, treatment regimens, disease progression and genomic testing results according to proprietary abstraction guidelines
Participate in the continual improvement of processes by providing feedback and recommendations pertaining to abstraction workflows, user experience, educational resources, features, and tools
Provide input into process checks and interface with quality management and biostatistics to resolve data issues
Availability during core business hours with flexibility to attend weekly team and company meetings as required
90-100% of effort dedicated to abstraction depending on business need
Perform other duties as assigned to support team and company goals

Qualification

Oncology data abstractionEHR platformsGenomic testingOncoEMREPICOncology Data Specialist certificationAttention to detailOrganizational skillsTeam playerCommunication skillsProblem solving

Required

3+ years of relevant experience with oncology data abstraction/curation from health information systems utilizing industry standard data ontologies
Ability to navigate electronic health records (EHRs) and follow proprietary guidance documents to curate a comprehensive data set including, but not limited to, the history, diagnosis, treatment, and disease status for cancer patients
Self-starter with ability to prioritize in complex and fast-evolving environments and a drive to get things done
Technical savvy and a strong desire to learn new systems and technology
Attention to detail and strong organizational skills
Team player who enjoys a collaborative environment, with ability to problem solve and provide constructive and articulate feedback
Excellent oral/written communication & interpersonal skills
Strong desire to drive a paradigm change in clinical research conduct and improve the quality of care for cancer patients
Ability to work in a HIPAA-compliant home office
Availability during core business hours with flexibility to attend weekly team and company meetings as required
90-100% of effort dedicated to abstraction depending on business need
Perform other duties as assigned to support team and company goals

Preferred

Bachelor's degree preferred
Oncology Data Specialist (ODS) certification preferred
Oncology/Hematology RN/LPN, or Clinical Research Associate (CRA), or certified in an NCRA Accredited Program or comparable professional experience, preferred
Experience in both solid tumor and hematologic malignancy abstraction
Familiarity with genomic testing in cancer, preferred
Experience with OncoEMR and/or EPIC, preferred
Familiarity with HIPAA and FDA regulated clinical trials research requirements, preferred

Benefits

Equity at hire
Discretionary annual bonus
Company benefits at 30+ hours/week
Competitive industry benefits
401K plan
Other great company “perks”

Company

N-Power Medicine, Inc.

twittertwitter
company-logo
N-Power Medicine is developing a radically faster, smarter paradigm for drug development that enables biopharma to move beyond traditional randomized clinical trials.

Funding

Current Stage
Growth Stage
Total Funding
unknown
Key Investors
Merck Global Health Innovation Fund
2024-05-21Series B

Leadership Team

leader-logo
Mark Lee
CEO & Co-Founder
linkedin
Company data provided by crunchbase